Herbas VPB

Print
EN | LT
LT - METHODS FOR PREDICTING AND MONITORING CANCER PATIENTS` RESPONSE TO TREATMENT BY MEASURING MYELOID DERIVED SUPPRESSOR CELLS (MDSCS)
EN - METHODS FOR PREDICTING AND MONITORING CANCER PATIENTS` RESPONSE TO TREATMENT BY MEASURING MYELOID DERIVED SUPPRESSOR CELLS (MDSCS)

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. G01N 33/50
G01N 33/574
European patent
(11) Number of the document 3215844
(13) Kind of document T
(96) European patent application number 15794313.5
Date of filing the European patent application 2015-08-19
(97) Date of publication of the European application 2017-09-13
(45) Date of publication and mention of the grant of the patent 2021-04-28
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/IL2015/050837
Date 2015-08-19
PCT application publication
(87) Number WO 2016/027273
Date 2016-02-25
Priority applications
(30) Number Date Country code
201462039156 P 2014-08-19 US
201462079018 P 2014-11-13 US
Inventors
(72)
BANIYASH, Michal, IL
LOTEM, Michal, IL
SADE-FELDMAN, Moshe, IL
KANTERMAN, Julia, IL
Grantee
(73) Hadasit Medical Research Services and Development Ltd., Kiryat Hadassah P.O. Box 12000, 9112001 Jerusalem, IL
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Hi Tech Park Edmond J. Safra Campus Givat Ram, 9139002 Jerusalem, IL
Title
(54) METHODS FOR PREDICTING AND MONITORING CANCER PATIENTS` RESPONSE TO TREATMENT BY MEASURING MYELOID DERIVED SUPPRESSOR CELLS (MDSCS)
  METHODS FOR PREDICTING AND MONITORING CANCER PATIENTS` RESPONSE TO TREATMENT BY MEASURING MYELOID DERIVED SUPPRESSOR CELLS (MDSCS)
Last update date 2021-08-04